5-methyl-3-(4-nitrophenyl)-1,2,4-oxadiazole, 100mg

2-Morpholinoethane-1,1-diol hydrochloride, 95+%, 100mg

2-Chloro-5-methylphenylboronic acid, 95.0%, 5g

4-chloro-6-ethyl-2-piperidin-1-ylpyrimidine, 95.0%, 10g

2-(chloromethyl)thieno[3,2-d]pyrimidin-4(3H)-one, 95.0%, 250mg

Mandelic acid 3,3,5-trimethylcyclohexyl ester, 94.0%, 250g

4-(4-METHOXYPHENYLSULFANYL)PIPERIDINE HCL, 95.0%, 250mg

4-(Phenyldiazenyl)benzoic acid, 5g

2-(Morpholine-4-carbonyl)phenol, 95+%, 5g

6-[(4-Chlorophenyl)sulfanyl]-3-pyridinylamine, 95+%, 250mg

GC capillary column ROTI®Cap-FFAP, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

OCTAHYDROPYRROLO[1,2-A][1,4]DIAZEPIN-5-ONE, 95.0%, 1g

3-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-propionaldehyde, 95.0%, 50g